ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2022
Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability.
Suaad Almajed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.